Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2017
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary) ; Ketorolac
- Indications Postoperative pain
- Focus Therapeutic Use
- 17 Jan 2017 Status changed from recruiting to completed.
- 25 Feb 2016 Planned End Date changed from 1 Jun 2015 to 1 Jun 2017, according to ClinicalTrials.gov record.
- 25 Feb 2016 Planned primary completion date changed from 1 Jun 2015 to 1 Mar 2017, according to ClinicalTrials.gov record.